Short-term treatment with cholestyramine increases long-acting anticoagulant rodenticide clearance from rabbits without affecting plasma vitamin K1 levels or blood coagulation
Toxicological Sciences · 26.06.2024 · 200 (1) · 137-145
DOI: 10.1093/toxsci/kfae053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 11.04.2024. Verfasst von Ruth N Muchiri und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Linus Pauling Institute, Oregon State University, Corvallis, Oregon 97331, USA. Hauptthemen laut MEDLINE: Rodenticides, Cholestyramine Resin, Anticoagulants, Vitamin K 1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NINDS NIH HHS, VA.
Abstract (Originalsprache)
Administration of high-dose vitamin K1 (VK1) overcomes coagulopathy and bleeding elicited by acute poisoning with long-acting anticoagulant rodenticides (LAARs). However, long-term (months) treatment is required due to long LAAR biological half-lives that may lead to poor compliance and recurrent coagulopathy. The half-lives of LAARs are extended by slow metabolism, and similar to warfarin, are thought to undergo enterohepatic recirculation. We now show that treatment with the bile acid sequestrant cholestyramine (CSA) administered concomitantly with VK1 decreases plasma LAAR levels and increases LAAR fecal excretion. Daily CSA treatment for 14 days did not reduce plasma VK1 levels, or increase prothrombin time. Collectively, these data show that CSA accelerates LAAR clearance from rabbits without adverse effects on VK1 anticoagulation, and could provide an additional therapeutic option for treatment of LAAR poisoning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Linus Pauling Institute, Oregon State University, Corvallis, Oregon 97331, USA.
- Department of Anesthesiology, University of Illinois, Chicago, Illinois 60612, USA.
- Department of Pharmacology, University of Illinois, Chicago, Illinois 60612, USA.
- Department of Medicine, University of Illinois, Chicago, Illinois 60612, USA.
- Research & Development Service, Jesse Brown VA Medical Center, Chicago, Illinois 60612, USA.
ORCID-Profile: Intakhar Ahmad, Richard B van Breemen, Douglas L Feinstein
Förderung
- NIEHS NIH HHS
- NINDS NIH HHS
- VA
- NIH HHS
- NIH
- Department of Veterans Affairs
Zitieren
APA
Muchiri, R. N., Rocha, J., Tandon, A., Chen, Y. L., Alemani, R., Ahmad, I., McDonald, Z., Lindeblad, M., Rubinstein, I., van Breemen, R. B., & Feinstein, D. L. (2024). Short-term treatment with cholestyramine increases long-acting anticoagulant rodenticide clearance from rabbits without affecting plasma vitamin K1 levels or blood coagulation. Toxicological Sciences, 200(1), 137-145. https://doi.org/10.1093/toxsci/kfae053
Vancouver
Muchiri RN, Rocha J, Tandon A, Chen YL, Alemani R, Ahmad I, et al. Short-term treatment with cholestyramine increases long-acting anticoagulant rodenticide clearance from rabbits without affecting plasma vitamin K1 levels or blood coagulation. Toxicological Sciences. 2024;200(1):137-145. doi:10.1093/toxsci/kfae053
BibTeX
@article{Muchiri2024,
author = {Muchiri, Ruth N and Rocha, Jackie and Tandon, Ankit and Chen, Yongmei Luo and Alemani, Rebecca and Ahmad, Intakhar and McDonald, Zachary and Lindeblad, Matthew and Rubinstein, Israel and van Breemen, Richard B and Feinstein, Douglas L},
title = {Short-term treatment with cholestyramine increases long-acting anticoagulant rodenticide clearance from rabbits without affecting plasma vitamin K1 levels or blood coagulation},
journal = {Toxicological Sciences},
year = {2024},
volume = {200},
number = {1},
pages = {137--145},
doi = {10.1093/toxsci/kfae053}
}
EUVIMED